Literature DB >> 34102950

The STRYDE limb lengthening nail is susceptible to mechanically assisted crevice corrosion: an analysis of 23 retrieved implants.

Morten Stendahl Jellesen1, Trine Nybo Lomholt2, Rikke Quist Hansen1,2, Troels Mathiesen2, Carsten Gundlach3, Søren Kold4, Tobias Nygaard5, Mindaugas Mikuzis4, Ulrik Kähler Olesen5, Jan Duedal Rölfing6.   

Abstract

Background and purpose - We noted several adverse events in patients in whom the first version of the STRYDE limb-lengthening nail (NuVasive Specialized Orthopaedics, San Diego, CA) had been implanted. Pain, osteolysis, periosteal reactions, and cortical hypertrophy at the nail junction were noted. Here, we present the analysis of 23 retrieved STRYDE implants.Materials and methods - We undertook visual inspection of the retrieved nails and screws, mechanical evaluation of the junction, micro-CT analyses, microscopic inspection of the bushing, screws, screw holes, and separated parts of the implants. Positive material identification (PMI) and energy-dispersive X-ray spectroscopy (EDS) were used to analyze the chemical composition. The hardness of the material was also investigated.Results - 20/23 retrieved nails had visible signs of corrosion, i.e., discoloration at the telescopic junction. Micro-CT verified corrosion attacks in 12/12 scanned bushings. Corrosion, predominantly mechanically assisted crevice corrosion, was observed at the locking screws and screw holes in 20/23 nails. Biological material inside the nail was observed in addition to oozing from the junction of 2 nails during hardware removal, which was experimentally reproducible. Notably, the mechanical construction of the bushing changed from PRECICE P2 to STRYDE nails.Interpretation - STRYDE nails are not hermetically sealed, and liquid can pass the bushing. Biodur 108 itself is corrosion resistant; however, mechanically assisted crevice corrosion of the bushing, locking screws, and screw holes may be aggravated due to manufacturing aiming for increased strength and hardness of the alloy.Observing several adverse events, we recently published a nationwide cross-sectional analysis of all 30 STRYDE limb- lengthening nails (NuVasive, Specialized Orthopedics, San Diego, CA) that were implanted in Denmark (Rölfing et al. 2021a). 27/30 STRYDE nails have now been removed and we present data from metallurgical analysis of 23 of the retrieved implants.

Entities:  

Year:  2021        PMID: 34102950     DOI: 10.1080/17453674.2021.1927506

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


  5 in total

1.  Letter to the editor on "STRYDE versus PRECICE magnetic internal lengthening nail for femur lengthening".

Authors:  Björn Vogt; Jan Duedal Rölfing; Robert Roedl; Adrien Frommer
Journal:  Arch Orthop Trauma Surg       Date:  2021-07-22       Impact factor: 3.067

2.  Limb reconstruction in a resource-limited environment.

Authors:  Nando Ferreira; Sanjeev Sabharwal; Gamal Ahmed Hosny; Hemant Sharma; Ashok Johari; Vasudevan P Nandalan; Mauro Vivas; Mangal Parihar; Selvadurai Nayagam; David Ferguson; Jan Duedal Rölfing
Journal:  SICOT J       Date:  2021-12-31

3.  Technical considerations and early results of magnetic compressive intramedullary nailing for humeral shaft delayed unions and nonunions.

Authors:  Daniel J Cognetti; Abdullah Ghali; Jose M Gutierrez-Naranjo; Jordan Handcox; Ravi Karia; Anil K Dutta
Journal:  JSES Int       Date:  2022-01-17

4.  Does Focal Osteolysis in a PRECICE Stryde Intramedullary Lengthening Nail Resolve after Explantation?

Authors:  Oliver C Sax; Larysa P Hlukha; Kyle A Kowalewski; John E Herzenberg; Philip K McClure
Journal:  Children (Basel)       Date:  2022-06-09

5.  Correction of post-traumatic lower-limb discrepancy with Precice intramedullary lengthening nails: a review of 34 adults with an average follow-up of 2 years.

Authors:  Christof Radler; Gabriel T Mindler; Alexandra Stauffer; Carina Weiß; Rudolf Ganger
Journal:  Acta Orthop       Date:  2022-09-02       Impact factor: 3.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.